The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel heterocyclic compounds, or a stereoisomer or pharmaceutically acceptable salt, solvate, or prodrug form thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
本发明一般涉及抑制
丝氨酸蛋白酶的化合物。具体而言,它涉及新颖的
杂环化合物,或其立体异构体或药用可接受的盐、溶剂合物或前药形式,这些化合物可用作凝血级联中
丝氨酸蛋白酶的选择性
抑制剂;例如凝血酶、第VIIa因子、第Xa因子、第XIa因子、第IXa因子和/或血浆激肽。具体而言,它涉及第VIIa因子
抑制剂的化合物。本发明还涉及包含这些化合物的药物组合物以及使用它们的方法。